The longitudinal quality of life (QoL) of COVID-19 survivors, especially those with post-acute sequelae (PASC) is not well described. We evaluated QoL in our COVID-19 survivor cohort over 6 months using the RAND SF-36 survey. From July 2020–March 2021 we enrolled 110 adults from the United States with a positive SARS-CoV-2 nasopharyngeal polymerase chain reaction (PCR) into the Northern Colorado Coronavirus Biobank (NoCo-COBIO). Demographic data and symptom surveillance were collected from 62 adults. In total, 42% were hospitalized, and 58% were non-hospitalized. The Rand SF-36 consists of 36 questions and 8 scales, and questions are scored 0–100. A lower-scale score indicates a lower QoL. In conclusion, hospitalization, PASC, and disease severity were associated with significantly lower scores on the RAND SF-36 in Physical Functioning, Role Limitation due to Physical Health, Energy/Fatigue, Social Functioning, and General Health. Long-term monitoring of COVID-19 survivors is needed to fully understand the impact of the disease on QoL and could have implications for interventions to alleviate suffering during recovery.
【저자키워드】 COVID-19, Hospitalization, COVID-19 severity, Post-acute sequelae of COVID-19 (PASC), Quality of life, SF-36, 【초록키워드】 SARS-CoV-2, Hospitalized, disease severity, Intervention, Symptom, Adults, Cohort, Biobank, PCR, Survivors, Surveillance, nasopharyngeal, PASC, demographic, limitation, positive, significantly lower, survivor, role, implication, polymerase chain, enrolled, described, collected, the United State, the disease, evaluated, indicate, question, alleviate, scored, 【제목키워드】 Quality, life, United State,